Code | 2438D | ||||||||||
MA number | 77/0284/19-S | ||||||||||
Product Form: | cps dur 30x0,5 mg/0,4 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Vipharm S.A., Poland | ||||||||||
Therapeutic Class: | 77 - SYMPATHOLYTICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | bottle HDPE | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 26.09.2019 |
Pediatric contraindication: | Yes |
PIL: | PIL_Alkapidan 0,5 mg/0,4 mg_cps dur_04_2020.doc |
SPC: | SPC_Alkapidan 0,5 mg/0,4 mg_cps dur_12_2020.doc |
Safety feature | Yes |
Data update: | 23.08.2024 |